Korro Bio Inc. (KRRO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Korro Bio Statistics
Share Statistics
Korro Bio has 9.37M shares outstanding. The number of shares has increased by 16.8% in one year.
Shares Outstanding | 9.37M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.75% |
Owned by Institutions (%) | n/a |
Shares Floating | 5.57M |
Failed to Deliver (FTD) Shares | 37 |
FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 751.59K, so 8.02% of the outstanding shares have been sold short.
Short Interest | 751.59K |
Short % of Shares Out | 8.02% |
Short % of Float | 13.5% |
Short Ratio (days to cover) | 7.19 |
Valuation Ratios
The PE ratio is -0.93 and the forward PE ratio is -3.71.
PE Ratio | -0.93 |
Forward PE | -3.71 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 0.44 |
P/FCF Ratio | -1 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Korro Bio Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.87, with a Debt / Equity ratio of 0.2.
Current Ratio | 8.87 |
Quick Ratio | 8.87 |
Debt / Equity | 0.2 |
Total Debt / Capitalization | 16.35 |
Cash Flow / Debt | -2.03 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.48% and return on capital (ROIC) is -41.63%.
Return on Equity (ROE) | -0.48% |
Return on Assets (ROA) | -0.37% |
Return on Capital (ROIC) | -41.63% |
Revenue Per Employee | 0 |
Profits Per Employee | -803.68K |
Employee Count | 101 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 27.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -34.74% in the last 52 weeks. The beta is 0, so Korro Bio 's price volatility has been lower than the market average.
Beta | 0 |
52-Week Price Change | -34.74% |
50-Day Moving Average | 43.22 |
200-Day Moving Average | 47.24 |
Relative Strength Index (RSI) | 32.49 |
Average Volume (20 Days) | 113.34K |
Income Statement
Revenue | n/a |
Gross Profit | -3.63M |
Operating Income | -84.53M |
Net Income | -81.17M |
EBITDA | -80.90M |
EBIT | n/a |
Earnings Per Share (EPS) | -53.09 |
Balance Sheet
The company has 166.15M in cash and 33.21M in debt, giving a net cash position of 132.94M.
Cash & Cash Equivalents | 166.15M |
Total Debt | 33.21M |
Net Cash | 132.94M |
Retained Earnings | -183.00M |
Total Assets | 243.54M |
Working Capital | 139.17M |
Cash Flow
In the last 12 months, operating cash flow was -67.28M and capital expenditures -7.84M, giving a free cash flow of -75.12M.
Operating Cash Flow | -67.28M |
Capital Expenditures | -7.84M |
Free Cash Flow | -75.12M |
FCF Per Share | -49.13 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KRRO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -160.1% |
FCF Yield | -24.18% |
Analyst Forecast
The average price target for KRRO is $125, which is 277% higher than the current price. The consensus rating is "Buy".
Price Target | $125 |
Price Target Difference | 277% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Stock Splits
The last stock split was on Nov 6, 2023. It was a backward split with a ratio of 1:50.
Last Split Date | Nov 6, 2023 |
Split Type | backward |
Split Ratio | 1:50 |
Scores
Altman Z-Score | 1.11 |
Piotroski F-Score | 2 |